These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TECNOGLASS INC
|
|
|
|
(Exact Name of Registrant as Specified in Its Charter)
|
|
Cayman Islands
|
N/A
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
x
|
|
|
(Do not check if smaller reporting company)
|
|
|
|
|
|
|
Page
|
|
Part
I.
Financial Information
|
|
|
Item 1. Financial Statements
|
|
|
Condensed Consolidated Balance Sheets
|
3
|
|
Condensed Consolidated Statements of Operations
|
4
|
|
Condensed Consolidated Statements of Changes in Shareholders’ (Deficit)/Equity
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Notes to Condensed Consolidated Financial Statements
|
7
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
21
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
23
|
|
Item 4. Controls and Procedures
|
23
|
|
Part II. Other Information
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
24
|
|
Item 6. Exhibits
|
25
|
|
Signatures
|
26
|
| 2 | ||
|
|
|
|
|
November
30, 2013 (unaudited) |
|
February 28,
2013 |
|
||
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
9,959
|
|
$
|
48,959
|
|
|
Interest on cash and cash equivalents held in trust
|
|
|
4,108
|
|
|
27,991
|
|
|
Total current assets
|
|
|
14,067
|
|
|
76,950
|
|
|
|
|
|
|
|
|
|
|
|
Long term assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents held in trust
|
|
|
42,740,000
|
|
|
42,740,000
|
|
|
Total long term assets
|
|
|
42,740,000
|
|
|
42,740,000
|
|
|
Total assets
|
|
$
|
42,754,067
|
|
$
|
42,816,950
|
|
|
LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Note payable to shareholder
|
|
$
|
100,000
|
|
$
|
-
|
|
|
Advances from shareholder
|
|
|
150,000
|
|
|
-
|
|
|
Accounts payable
|
|
|
240,568
|
|
|
56,484
|
|
|
Total current liabilities
|
|
|
490,568
|
|
|
56,484
|
|
|
|
|
|
|
|
|
|
|
|
Long term liabilities:
|
|
|
|
|
|
|
|
|
Warrant liability
|
|
|
14,270,000
|
|
|
10,969,000
|
|
|
Total liabilities
|
|
|
14,760,568
|
|
|
11,025,484
|
|
|
COMMITMENTS AND CONTINGENCY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares, subject to possible conversion, 3,674,999 shares at conversion value
|
|
|
37,397,490
|
|
|
37,397,490
|
|
|
Shareholders’ deficit
|
|
|
|
|
|
|
|
|
Preferred shares, $0.0001 par value, 1,000,000 authorized shares and no
outstanding shares |
|
|
-
|
|
|
-
|
|
|
Ordinary shares, $0.0001 par value, 100,000,000 authorized shares; 1,575,001 and
1,575,001 issued and outstanding shares, respectively (which excludes 3,674,999 and 3,674,999 shares subject to possible conversion, respectively) |
|
|
158
|
|
|
158
|
|
|
Additional paid-in capital
|
|
|
5,790,425
|
|
|
5,790,425
|
|
|
Deficit accumulated during the development stage
|
|
|
(15,194,574)
|
|
|
(11,396,607)
|
|
|
Total shareholders’ deficit
|
|
|
(9,403,991)
|
|
|
(5,606,024)
|
|
|
Total liabilities and shareholders’ deficit
|
|
$
|
42,754,067
|
|
$
|
42,816,950
|
|
| 3 | ||
|
|
|
|
|
For the three
months ended November 30, 2013 |
|
For the three
months ended November 30, 2012 (Revised) |
|
For the nine months
ended November 30, 2013 |
|
For the nine months
ended November 30, 2012 (Revised) |
|
For the period
September 21, 2011 (inception) to November 30, 2013 |
|
|||||
|
Operating and formation costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses
|
|
$
|
322,365
|
|
$
|
95,034
|
|
$
|
518,504
|
|
$
|
319,865
|
|
$
|
974,102
|
|
|
Loss from operations
|
|
|
(322,365)
|
|
|
(95,034)
|
|
|
(518,504)
|
|
|
(319,865)
|
|
|
(974,102)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrants
|
|
|
(3,132,000)
|
|
|
1,038,000
|
|
|
(3,301,000)
|
|
|
(10,738,000)
|
|
|
(14,270,000)
|
|
|
Interest income
|
|
|
2,580
|
|
|
9,570
|
|
|
21,537
|
|
|
22,027
|
|
|
49,528
|
|
|
Net income (loss)
|
|
$
|
(3,451,785)
|
|
$
|
952,536
|
|
$
|
(3,797,967)
|
|
$
|
(11,035,838)
|
|
$
|
(15,194,574)
|
|
|
Weighted average shares outstanding, basic and
diluted |
|
|
1,575,001
|
|
|
1,575,001
|
|
|
1,575,001
|
|
|
1,575,001
|
|
|
|
|
|
Basic and diluted net loss per share
|
|
$
|
(2.19)
|
|
$
|
0.60
|
|
$
|
(2.41)
|
|
$
|
(7.01)
|
|
|
|
|
| 4 | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
During the
|
|
Total
|
|
|||
|
|
|
Ordinary Shares
(1)
(2)
|
|
Paid-in
|
|
Development
|
|
Shareholders’
|
|
|||||||
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Stage
|
|
(Deficit) Equity
|
|
|||||
|
Ordinary shares issued September 21, 2011 at
approximately $0.02 per share for cash |
|
|
1
|
|
$
|
-
|
|
$
|
-
|
|
$
|
-
|
|
$
|
-
|
|
|
Ordinary shares issued October 25, 2011 at
approximately $0.02 per share for cash |
|
|
1,049,999
|
|
|
105
|
|
|
24,895
|
|
|
-
|
|
|
25,000
|
|
|
Net Loss
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(17,327)
|
|
|
(17,327)
|
|
|
Balance at February 29, 2012
|
|
|
1,050,000
|
|
|
105
|
|
|
24,895
|
|
|
(17,327)
|
|
|
7,673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of 4,000,000 Units on March 22, 2012, net of underwriter’s discount and offering expenses (includes 3,499,999 shares subject to possible conversion)
|
|
|
4,000,000
|
|
|
400
|
|
|
38,322,573
|
|
|
-
|
|
|
38,322,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Underwriters’ Options
|
|
|
-
|
|
|
-
|
|
|
500,100
|
|
|
-
|
|
|
500,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Insider Warrants
|
|
|
-
|
|
|
-
|
|
|
2,400,000
|
|
|
-
|
|
|
2,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of 200,000 Units on March 30, 2012, net of underwriter’s discount (includes 175,000 shares subject to possible conversion)
|
|
|
200,000
|
|
|
20
|
|
|
1,939,980
|
|
|
-
|
|
|
1,940,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds subject to possible conversion (3,674,999)
|
|
|
(3,674,999)
|
|
|
(367)
|
|
|
(37,397,123)
|
|
|
-
|
|
|
(37,397,490)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
|
|
|
|
|
|
|
|
|
|
(11,379,280)
|
|
|
(11,379,280)
|
|
|
Balance at February 28, 2013
|
|
|
1,575,001
|
|
|
158
|
|
|
5,790,425
|
|
|
(11,396,607)
|
|
|
(5,606,024)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
|
|
|
|
|
|
|
|
|
|
(3,797,967)
|
|
|
(3,797,967)
|
|
|
Balance at November 30, 2013
|
|
|
1,575,001
|
|
$
|
158
|
|
$
|
5,790,425
|
|
$
|
(15,194,574)
|
|
$
|
(9,403,991)
|
|
|
|
(1)
|
Share amounts have been retroactively restated to reflect the contribution to the Company of 287,500 ordinary shares by the Initial Shareholders on March 9, 2012 (Note 8).
|
|
|
|
|
|
|
(2)
|
Reflects an aggregate of 100,000 shares forfeited by the Initial Shareholders on May 1, 2012 because the underwriters’ over-allotment option was not exercised in full (Note 8).
|
| 5 | ||
|
|
|
|
|
For the nine
months ended November 30, 2013 |
|
For the nine
months ended November 30, 2012 (Revised) |
|
For the period
September 21, 2011 (Inception) to November 30, 2013 |
|
|||
|
Cash Flow From Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(3,797,967)
|
|
$
|
(11,035,838)
|
|
$
|
(15,194,574)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
Change in warrant liability
|
|
|
3,301,000
|
|
|
10,738,000
|
|
|
14,270,000
|
|
|
Accrued interest
|
|
|
23,883
|
|
|
(22,027)
|
|
|
(4,108)
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
184,084
|
|
|
(13,224)
|
|
|
240,568
|
|
|
Net cash used in operating activities
|
|
|
(289,000)
|
|
|
(333,089)
|
|
|
(688,114)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
Investment in cash and cash equivalents held in trust
|
|
|
-
|
|
|
(42,740,000)
|
|
|
(42,740,000)
|
|
|
Net cash used in investing activities
|
|
|
-
|
|
|
(42,740,000)
|
|
|
(42,740,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow From Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of ordinary shares to initial shareholders
|
|
|
-
|
|
|
-
|
|
|
25,000
|
|
|
Proceeds from Public Offering, net of offering costs of $1,449,055
|
|
|
-
|
|
|
38,550,945
|
|
|
38,550,945
|
|
|
Payment of additional offering costs
|
|
|
-
|
|
|
-
|
|
|
(108,722)
|
|
|
Proceeds from Warrant Offering
|
|
|
-
|
|
|
2,400,000
|
|
|
2,400,000
|
|
|
Proceeds from Underwriters Options
|
|
|
-
|
|
|
500,100
|
|
|
500,100
|
|
|
Proceeds from Over Allotment, net of offering costs of $60,000
|
|
|
-
|
|
|
1,940,000
|
|
|
1,940,000
|
|
|
Proceeds from note payable to shareholder
|
|
|
100,000
|
|
|
-
|
|
|
302,000
|
|
|
Proceeds from advance from shareholder
|
|
|
150,000
|
|
|
-
|
|
|
-
|
|
|
Repayment of advances from shareholder
|
|
|
-
|
|
|
(71,250)
|
|
|
(71,250)
|
|
|
Repayment of note payable to shareholder
|
|
|
-
|
|
|
(100,000)
|
|
|
(100,000)
|
|
|
Net cash provided by financing activities
|
|
|
250,000
|
|
|
43,219,795
|
|
|
43,438,073
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(39,000)
|
|
|
146,706
|
|
|
9,959
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
48,959
|
|
|
3,014
|
|
|
-
|
|
|
Cash and cash equivalents, ending of period
|
|
$
|
9,959
|
|
$
|
149,720
|
|
$
|
9,959
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non cash financing activity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment of offering costs by shareholder and included in note payable to shareholder
|
|
$
|
-
|
|
$
|
-
|
|
$
|
48,000
|
|
|
Payments of offering costs advanced from shareholder
|
|
$
|
-
|
|
$
|
71,250
|
|
$
|
71,250
|
|
| 6 | ||
|
|
| 7 | ||
|
|
| 8 | ||
|
|
| 9 | ||
|
|
| 10 | ||
|
|
|
|
•
|
Level 1. Observable inputs such as quoted prices in active markets;
|
|
|
•
|
Level 2. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
|
|
|
•
|
Level 3. Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
|
(a).
|
Market approach. Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities;
|
|
|
(b).
|
Cost approach. Amount that would be required to replace the service capacity of an asset (replacement cost); and
|
|
|
(c).
|
Income approach. Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing and excess earnings models).
|
|
|
|
November 30,
|
|
Quoted Prices in
Active Markets |
|
Significant Other
Observable Inputs |
|
Significant
Unobservable Inputs |
|
||||
|
|
|
2013
|
|
(Level 1)
|
|
(Level 2)
|
|
(Level 3)
|
|
||||
|
Restricted cash and cash equivalents held in Trust Account and accrued interest
|
|
$
|
42,744,108
|
|
$
|
42,744,108
|
|
$
|
-
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant Liability
|
|
$
|
14,270,000
|
|
$
|
-
|
|
$
|
-
|
|
$
|
14,270,000
|
|
|
|
|
February 28,
|
|
Quoted Prices in
Active Markets |
|
Significant Other
Observable Inputs |
|
Significant
Unobservable Inputs |
|
||||
|
|
|
2013
|
|
(Level 1)
|
|
(Level 2)
|
|
(Level 3)
|
|
||||
|
Restricted cash and cash equivalents held in Trust Account and accrued interest
|
|
$
|
42,767,991
|
|
$
|
42,767,991
|
|
$
|
-
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant Liability
|
|
$
|
10,969,000
|
|
$
|
-
|
|
$
|
-
|
|
$
|
10,969,000
|
|
| 11 | ||
|
|
|
Balance February 28, 2013
|
|
$
|
10,969,000
|
|
|
Fair Value adjustment
|
|
|
3,301,000
|
|
|
Balance November 30, 2013
|
|
$
|
14,270,000
|
|
|
|
|
November
30, 2013 |
|
|
February 28,
2013 |
|
|
||
|
The Company’s stock price
|
|
$
|
10.17
|
|
|
$
|
9.90
|
|
|
|
Dividend yield (per share)
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
Risk-free interest rate
|
|
|
0.56
|
%
|
|
|
0.77
|
%
|
|
|
Expected term
|
|
|
3.08 years
|
|
|
|
3.84 years
|
|
|
|
Expected volatility rate
|
|
|
15.0
|
%
|
|
|
17.0
|
%
|
|
| 12 | ||
|
|
| 13 | ||
|
|
| 14 | ||
|
|
| 15 | ||
|
|
| 16 | ||
|
|
| 17 | ||
|
|
|
|
·
|
an aggregate of
20,567,141
ordinary shares of the Company, subject to adjustment upon certain events; and
|
|
|
·
|
an aggregate of
3,000,000
ordinary shares (the “Earnout Shares”) to be released upon the achievement of certain targets described below.
|
| 18 | ||
|
|
|
|
|
Ordinary Share
Price Target |
|
EBITDA Target
|
|
Number of Earnout Shares
|
|
|||||||||
|
|
|
|
|
|
Minimum
|
|
Maximum
|
|
Minimum
|
|
Maximum
|
|
||||
|
Fiscal year ending 12/31/14
|
|
$
|
12.00 per share
|
|
$
|
30,000,000
|
|
$
|
36,000,000
|
|
|
416,667
|
|
|
500,000
|
|
|
Fiscal year ending 12/31/15
|
|
$
|
13.00 per share
|
|
$
|
35,000,000
|
|
$
|
40,000,000
|
|
|
875,000
|
|
|
1,000,000
|
|
|
Fiscal year ending 12/31/16
|
|
$
|
15.00 per share
|
|
$
|
40,000,000
|
|
$
|
45,000,000
|
|
|
1,333,333
|
|
|
1,500,000
|
|
| 19 | ||
|
|
| 20 | ||
|
|
| 21 | ||
|
|
| 22 | ||
|
|
| 23 | ||
|
|
|
Name
|
|
|
Number of Shares
|
|
|
A. Lorne Weil
|
|
|
717,499
|
|
|
Julio A. Torres
|
|
|
50,000
|
|
|
Martha L. Byorum
|
|
|
50,000
|
|
|
Capital Advisory Partners L.A.
|
|
|
50,000
|
|
|
Eduardo Robayo
|
|
|
50,000
|
|
|
B. Luke Weil
|
|
|
460,000
|
|
|
Eric Carrera
|
|
|
2,500
|
|
|
Robert Stevens
|
|
|
7,500
|
|
|
LWEH LLC
|
|
|
50,000
|
|
| 24 | ||
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32
|
|
Certification of Chief Executive Officers pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101
|
|
Financial statements from the Quarterly Report on Form 10-Q of Tecnoglass Inc. for the quarter ended November 30, 2013, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statement of Changes in Stockholders' Equity, (iv) Condensed Consolidated Statement of Cash Flows and (v) Notes to Unaudited Condensed Consolidated Financial Statements, as blocks of text and in detail.*
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document*
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document *
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document *
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document *
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document*
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document *
|
| 25 | ||
|
|
|
|
TECNOGLASS INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Jose M. Daes
|
|
|
|
Jose M. Daes
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal executive officer)
|
|
|
|
|
|
|
By:
|
/s/ Joaquin Fernandez
|
|
|
|
Joaquin Fernandez
|
|
|
|
Chief Financial Officer
|
|
|
|
(Principal financial and accounting officer)
|
|
|
|
|
|
Date:
January 21, 2014
|
|
|
| 26 | ||
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|